Home/Filings/4/0001209191-18-009214
4//SEC Filing

Codner Iris Beck 4

Accession 0001209191-18-009214

CIK 0000818686other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:29 PM ET

Size

8.3 KB

Accession

0001209191-18-009214

Insider Transaction Report

Form 4
Period: 2018-02-09
Codner Iris Beck
EVP Global Brand&Communication
Transactions
  • Award

    Stock Options (right to buy)

    2018-02-09+86,76286,762 total
    Exercise: $18.61Exp: 2028-02-08Ordinary Shares (86,762 underlying)
  • Award

    Restricted Share Units

    2018-02-09+34,03134,031 total
    Ordinary Shares (34,031 underlying)
Footnotes (4)
  • [F1]Stock options were granted on February 9, 2018, with 28,920 vesting on each of February 9, 2020 and February 9, 2021 and 28,922 vesting on February 9, 2022.
  • [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F3]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F4]Restricted share units were granted on February 9, 2018, with 11,343 vesting on each of February 9, 2020 and February 9, 2021 and 11,345 vesting on February 9, 2022.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001721514

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:29 PM ET
Size
8.3 KB